Dearborn Partners LLC Holds Stake in Cvs Health Corp (CVS)

June 20, 2017 - By Hazel Jackson

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It turned negative, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Signature Finance Mngmt invested 0.12% of its portfolio in CVS Health Corp (NYSE:CVS). First Manhattan has 1.27% invested in CVS Health Corp (NYSE:CVS) for 2.65 million shares. Philadelphia Tru has invested 1.94% in CVS Health Corp (NYSE:CVS). Sii Invests Wi invested 0.1% in CVS Health Corp (NYSE:CVS). New Mexico Educational Retirement Board has invested 0.42% of its portfolio in CVS Health Corp (NYSE:CVS). Invesco has 0.12% invested in CVS Health Corp (NYSE:CVS) for 4.56M shares. Great Lakes Advisors Limited Liability Corporation holds 761,862 shares or 1.58% of its portfolio. Stelac Advisory Service Ltd Liability Corporation holds 0.19% or 7,103 shares. Sterneck Capital Management Ltd Liability Company has invested 0.33% of its portfolio in CVS Health Corp (NYSE:CVS). Hedeker Wealth Limited Liability Company has 15,173 shares for 0.99% of their portfolio. Duff And Phelps Management invested 0.01% in CVS Health Corp (NYSE:CVS). Chatham Group has invested 0.12% of its portfolio in CVS Health Corp (NYSE:CVS). Univest Corporation Of Pennsylvania reported 1.13% in CVS Health Corp (NYSE:CVS). Boyar Asset Mngmt Incorporated has invested 0.58% in CVS Health Corp (NYSE:CVS). Dumont Blake Advsrs Ltd Liability holds 15,832 shares.

Since February 1, 2017, it had 0 insider purchases, and 7 sales for $40.53 million activity. $1.88 million worth of CVS Health Corp (NYSE:CVS) was sold by Brennan Troyen A on Tuesday, March 21. Another trade for 14,104 shares valued at $1.13M was made by Sussman Andrew on Monday, March 13. MERLO LARRY J sold $5.99M worth of stock. Denton David M also sold $7.71M worth of CVS Health Corp (NYSE:CVS) on Friday, March 10. 61,196 shares were sold by Roberts Jonathan C, worth $4.90 million. $479,908 worth of stock was sold by Boratto Eva C on Friday, March 17.

Dearborn Partners Llc increased its stake in Cvs Health Corp (CVS) by 30.12% based on its latest 2016Q4 regulatory filing with the SEC. Dearborn Partners Llc bought 48,527 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 209,649 shares of the medical and nursing services company at the end of 2016Q4, valued at $16.54M, up from 161,122 at the end of the previous reported quarter. Dearborn Partners Llc who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $80.64B market cap company. It closed at $78.1 lastly. It is down 24.40% since June 20, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Dearborn Partners Llc, which manages about $1.48B and $1.20B US Long portfolio, decreased its stake in Polaris Inds Inc Com (NYSE:PII) by 120,345 shares to 3,251 shares, valued at $268,000 in 2016Q4, according to the filing.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Fool.com which released: “Why Whole Foods Market’s Gain Is CVS Health’s and Walgreens’ Loss Today” on June 16, 2017, also Seekingalpha.com with their article: “CVS: A Value Trap?” published on June 12, 2017, Fool.com published: “Better Buy: CVS Health Corporation vs. Walgreen Boots Alliance” on May 27, 2017. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Seekingalpha.com and their article: “CVS Health: Is The Amazon Threat Realistic?” published on June 12, 2017 as well as Fool.com‘s news article titled: “Better Buy: CVS Health Corporation vs. The Kroger Co.” with publication date: May 29, 2017.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. On Monday, November 2 the stock rating was maintained by S&P Research with “Strong Buy”. The stock of CVS Health Corp (NYSE:CVS) has “Equal-Weight” rating given on Monday, June 20 by Morgan Stanley. The firm has “Outperform” rating given on Monday, November 2 by Oppenheimer. Deutsche Bank maintained it with “Hold” rating and $117 target in Wednesday, July 22 report. The stock of CVS Health Corp (NYSE:CVS) earned “Buy” rating by Mizuho on Thursday, June 23. The rating was maintained by Argus Research on Monday, August 10 with “Buy”. The rating was initiated by Tigress Financial on Friday, April 28 with “Buy”. RBC Capital Markets maintained CVS Health Corp (NYSE:CVS) on Wednesday, August 5 with “Outperform” rating. JP Morgan maintained CVS Health Corp (NYSE:CVS) rating on Monday, November 2. JP Morgan has “Overweight” rating and $123 target. As per Monday, February 6, the company rating was downgraded by Atlantic Securities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.